In the human isolated myocardium, acetylcholine (10 -9 to 10 -3 M) elicited a biphasic inotropic effect (a decrease in the lower and an increase in the higher concentration range) in atrial and a positive inotropic effect in ventricular trabeculae. However, under conditions of raised contractility achieved by exposure to noradrenaline (10 -5 M), only negative inotropic effects were observed in both atria and ventricles. Atropine (10 -6 M), but not propranolol (10 -6 M), antagonized both positive and negative inotropic effects of acetylcholine, thus showing that the responses were mediated by muscarinic acetylcholine receptors. The use of subtype selective muscarinic receptor antagonists (10 -7 to 10 -5 M), pirenzepine (
I. Introduction
It is well known that acetylcholine causes negative inotropic and chronotropic effects in the mammalian heart, including humans (Brodde et al., 1992; Caulfield, 1993; B6hm et al., 1994; Landzberg et al., 1994) . In addition, studies have shown that acetylcholine can elicit a positive inotropic response in isolated cardiac tissue of some species (Endoh and Blinks, 1984; Tajima et al., 1987; Eglen et al., 1988) . In our previous study in the human isolated myocardium, we reported that acetylcholine elicited a biphasic response (an initial decrease followed by an increase in contractility back to baseline values) in the atrial trabeculae, whereas only a positive inotropic effect was noticed in the ventricular trabeculae (Duet al., 1994) . This latter effect was not observed earlier (Jakob et al., 1989; Deighton et al., 1990; B6hm et al., 1994) .
Five muscarinic acetylcholine receptor subtype genes have been cloned and expressed, but only muscarinic M 2 receptors have been detected in the human heart (Maeda et al., 1988; Ford et al., 1992; Caulfield, 1993) . Correspondingly, the responses to muscarinic receptor agonists in the cardiac muscle appear to be mediated by the activation of well-characterized muscarinic M 2 receptors, which are coupled to different signal transduction pathways (Schimerlik, 1989) . However, the cardiac effects of muscarinic receptor stimulation are not yet fully understood and evidence is emerging that, besides the muscarinic M 2 receptor, other muscarinic receptor subtypes are also expressed in the heart. For example, the muscarinic M 1 receptor seems to mediate positive inotropic effects in cells isolated from adult guinea-pig ventricles (Gallo et al., 1993) as well as the increase in automaticity in canine Purkinje fibres (Rosen et al., 1990) . Furthermore, it has been reported that low doses of pirenzepine ( < 3 rag) cause bradycardia that coincides with the blockade of muscarinic M1 receptors in humans . Thus, it is suggested that although the predominant population of muscarinic receptors at postsynaptic sites in the heart is of the M 2 subtype, a small population of M 1 subtype is also present (Watson et al., 1983; Evans et al., 1985) .
The purpose of the present study was to characterize the receptors involved in the observed inotropic effects of acetylcholine in the human cardiac tissue (Duet al., 1994) by using relatively selective antagonists at the muscarinic M1, M 2 or M 3 receptors (Doods et al., 1987) as well as a selective agonist at the muscarinic M 1 receptor. A part of this investigation has been presented at the last winter meeting of the British Pharmacological Society (Du et al., 1995) .
Material and methods

Preparations
Right atrial and left ventricular trabeculae were obtained from 61 heart beating organ donors (43 males, 18 females aged 2-55 years), who died of non-cardiac disorders (36 cerebrovascular accident, 20 polytrauma, 5 hypoxia) less than 24 h before the tissue was brought to the laboratory. The hearts were kindly provided by the Rotterdam Heart Valve Bank (Bio Implant Services Foundation/Eurotransplant Foundation) after removal of the aortic and pulmonary valves for homograft valve implantation. The hearts were stored at 0-4°C in a sterile organ protecting solution (UW, Eurocollins, or HTK-Brettschneider, see Ploeg et al., 1992) immediately following circulatory arrest. After excision, tissue samples were placed in ice-chilled oxygenated Krebs buffer (composition in Mm: NaC1 118, KCI 4.7, CaC12 2.5, MgSO 4 1.2, NaHCO 3 25, KHPO 4 1.2 and glucose 8.3) and atrial and ventricular trabeculae (< 1 mm thickness) were carefully dissected free. The trabeculae were mounted in organ baths containing Krebs buffer (37°C, gassed with 95% 0 2 and 5% CO 2) and paced at 1 Hz using electrical field stimulation (3 ms, voltage 20% above threshold). The developed tension was recorded using isometric Harvard transducers and Goerz flatbed recorders Duet al., 1994) . Based on preliminary experiments, the chosen optimal resting load, yielding the highest developed tension, was 750 mg and 1950 mg for atrial and ventricular trabeculae, respectively.
Experimental protocol
After stabilization, the resting tension and baseline contractile force were measured. A concentration-response curve for noradrenaline was obtained to check the viability of the tissues Du et al., 1994) . Tissues with less than 25 mg response to 10 -5 M noradrenaline were excluded from further analysis.
After washing (6 times) and stabilization, 10 -6 M physostigmine was added to the Krebs buffer in experiments involving acetylcholine to prevent its rapid degradation by cholinesterase (see Chatonnet and Lockridge, 1989) . One cumulative concentration-response curve for acetylcholine (10 -9 to 10 -3 M) was constructed in each atrial and ventricular preparation, in the absence (control) or after 30 min incubation with one of the following antagonists: propranolol (10 -6 M, non-selective /3-adrenoceptor antagonist), atropine (10-6 M, non-selective muscarinic receptor antagonist), pirenzepine (10 -7, 10 -6 or 10 -5 M, muscarinic M 1 receptor antagonist, Hammer et al., 1980) , AF-DX 116 (10 -7, 10 -6 or 10 -5 M, muscarinic M e receptor antagonist, Giachetti et al., 1986) and HHSiD (10 -6 or 10 -5 M, muscarinic M 3 receptor antagonist, Lambrecht et al., 1989) . In addition, the effects of acetylcholine on trabeculae pre-stimulated with noradrenaline (10 -5 M) were investigated either in the absence or presence of 10 -6 M atropine.
Since not all effects of acetylcholine could be fully explained after the use of antagonists, we also investigated the effects of a muscarinic M 1 receptor agonist, McN-A-343. One cumulative concentration-response curve for McN-A-343 (10 -9 to 10 -3 M) was obtained in each atrial and ventricular preparation. In addition, in the atrial tissue, cumulative concentration-response curves for McN-A-343 (10 -9 to 10 -3 M) were also constructed following a maximal negative inotropic effect induced by acetylcholine (10 -9 tO >_ 10 -6 M), in the absence or presence of pirenzepine (10 -5 M).
There was no apparent difference in the responses to noradrenaline or acetylcholine observed in trabecu-lae obtained from subjects of different age or dying from different causes. This is also true for a number of other subtances, including 5-hydroxytryptamine and histamine Du et al., ,1994 .
Data presentation and analysis
Data are presented as means + S.E.M. Baseline values for atrial and ventricular tissue were compared using an unpaired t-test. The effects of acetylcholine and McN-A-343 in the absence or presence of various antagonists were analyzed using an analysis of variance for repeated measurements. Differences were regarded statistically significant, if P < 0.05. Since the negative inotropic response in atrial and the positive inotropic response in ventricular tissues reached their maximum, the curves were fitted to a four-parameter logistic function (De Lean et al., 1978) 
Chemicals used
The chemicals used in the present study were: acetylcholine chloride (Ciba, Breda, Netherlands), AF-DX 116 (ll-({2-[(diethylamino)-methyl]-l-piperidyl} acetyl) -5,11-dihydro-6 H-pyridol[ 2,3-b ] [1, 4] benzodiazepine-6-one base; Thomae, Biberach/Riss, Germany), atropine sulphate (Centrafarm, Etten-Leur, Netherlands), HHSiD (p-fluorohexahydro-siladifenidol hydrochloride; Research Biochemicals International, Natick, MA, USA), McN-A-343 (4-(m-chlorophenylcarbamoyloxy)-2-butynyltrimethylammonium chloride; McNiel, Fort Washington, PA, USA), noradrenaline bitartrate (Sigma, St. Louis, MO, USA), physostigmine salicylate (Sandoz, Basel, Switzerland), pirenzepine base (Thomae, Biberach/Riss, Germany), propranolol hydrochloride (Imperial Chemical Industries, Macclesfield, UK).
Results
Viability of the tissues
The baseline contractile force was significantly lower in the atrial (97 + 13 mg, n = 57) than in ventricular (236 + 30 mg, n = 54) tissue. In both tissues, nor- adrenaline (10 -8 M to 10 -5 M) increased contractile force in a concentration-dependent manner. After exposure to 10 -5 M noradrenaline, the force of contraction went up to 381 + 35 mg (n = 57) and 627 + 65 mg (n = 54) in the atrial and ventricular trabeculae, respectively.
Inotropic responses to acetylcholine in atrial and uentricular trabeculae Effect on the baseline contractility
The effect of acetylcholine on the baseline atrial and ventricular contractility as well as the influence of atropine and propranolol are shown in Fig. 1 . In right atrial trabeculae, acetylcholine exhibited a biphasic contractile response consisting of an initial decrease followed by an increase. At low concentrations (10 -9 to 10 -7 M), acetylcholine clearly decreased the baseline contractile force (maximum decrease from baseline values: 67 + 13% at 10 -7 M), but with higher concentrations the contractile force started to increase towards baseline values (0 _+ 23% change from baseline values at ]0 -3 U). If after exposure to ]0 -7 M acetylcholine higher concentrations were not used, the contractile force remained depressed without coming back towards baseline values. However, when 10 -4 M acetylcholine was administrated without the preceding part of the concentration-response curve, no positive inotropic effect was observed (data not shown). In contrast to atria, acetylcholine caused only a positive inotropic effect in left ventricular trabeculae. The maximum increase in contractile force (53 _+ 17% from baseline values) was observed at 10 -3 M.
Atropine (]0 -6 M) effectively antagonized both the negative and positive inotropic effects of acetylcholine in atrial as well as the positive inotropic effect in ventricular trabeculae. Since in the presence of atropine a complete concentration-response curve to acetylcholine could not be constructed, pD 2 values of acetylcholine were not calculated. However, from Fig.  1 it can be seen that atropine shifted the concentration-response curve to the right by more than 3 and 4 log units in atrial and ventricular trabeculae, respectively. Propranolol (10 -6 M) did not modify the responses to acetylcholine.
Effect on noradrenaline-stimulated contractility
In the presence of noradrenaline (10 -5 M), acetylcholine produced only a negative inotropic effect in both atrial and ventricular trabeculae (Fig. 2) . The reduction of the contractile force by 10 -3 M acetylcholine was from 504 + 141 to 43 + 6 mg (86 _ 4%) in atrial trabeculae (n = 7) and from 463 + 93 to 288 + 59 mg (39 + 5%) in ventricular trabeculae (n = 6). The pD 2 value for acetylcholine was 7.0 + 0.6 (n = 5) and 6.8 + 0.9 (n = 6) in the atrial and ventricular tissues, respectively.
Atropine shifted the concentration-response curve for acetylcholine to the right in both atrial and ventricular tissue following pre-stimulation with 10 -5 M noradrenaline (Fig. 2) . The pD 2 values for acetylcholine were decreased in both atrial (4.5 + 0.1; n = 7) and ventricular (4.8 + 0.3; n = 5) trabeculae.
Effect of the muscarinic receptor antagonists on acetylcholine-induced inotropic responses
Right atrium Fig. 3 presents concentration-response curves to acetylcholine in atrial trabeculae in the absence (control) or presence of the three relatively selective muscarinic receptor antagonists, whereas the relevant parameters of these curves are summarized in Table 1 . The muscarinic M t receptor antagonist pirenzepine (10 -7, 10 -6 or 10 -5 M) did not significantly change the negative inotropic effect of acetylcholine (10 -9 to 10 -6 M), whereas the positive inotropic effect of acetylcholine (10 -6 to 10 -3 M) was significantly reduced by pirenzepine at the highest concentration (10 -5 M; pK B could not be calculated). The muscarinic M e receptor antagonist AF-DX 116 did not significantly affect the negative inotropic effect of acetylcholine at 10 -7 M, but 10 -6 M AF-DX 116 produced a parallel shift to the right of the acetylcholine curve (apparent PKB: 6.7 + 0.4; n = 8) and 10 -5 M AF-DX 116 completely abolished the negative inotropic effect. AF-DX 116 either did not affect (10 -7 and 10 -6 M) or even seemed to increase (10 -5 M) the positive inotropic Table 1 Maximum negative (with apparent pD 2) and positive inotropic effects in atrial and maximum positive inotropic effect (with apparent pD 2) in ventricular trabeculae induced by acetylcholine component of the effects of acetylcholine. The preferential muscarinic M 3 receptor antagonist HHSiD (10 -6 M) failed to modify the effects of acetylcholine, but its higher concentration (10 -5 M) reduced the negative inotropic component (apparent pKB: 6.0 -t-0.6; n = 6), without affecting the positive inotropic component.
Left ventricle
The effects of muscarinic receptor antagonists on acetylcholine-induced positive inotropic effects in ventricular trabeculae are shown in Fig. 4 and Table 1 . Pirenzepine did not efficiently antagonize the responses to acetylcholine; only at 10 -5 M pirenzepine, the curve for the acetylcholine seemed to be slightly shifted to the right (apparent pKB: 5.7 + 0.5; n = 6). On the other hand, AF-DX 116 (10 -6 and 10 -5 M) caused a concentration-dependent antagonism of the responses to acetylcholine (apparent pKB: 6.7-1-0.6 and 6.2 _+ 0.3, respectively; n = 6 each). HHSiD failed to modify the responses to acetylcholine.
Effects of MeN-A-343
Baseline contractility
The effects of MeN-A-343 (10 -9 to 10 -3 M), a relatively selective muscarinic M 1 receptor agonist, on the baseline contractility in the atrial and ventricular trabeculae are presented in 
Acetylcholine-induced depressed contractility in atrial trabeculae
Discussion
Involvement of the muscarinic receptors in acetylcholine-induced responses
The results from the present and previous (Duet al., 1994) studies show that in the human isolated myocardium acetylcholine elicits complex inotropic effects, consisting of a biphasic response (decrease followed by increase at high concentrations) in the atrial baseline contractility and only an increase in the ventricular baseline contractility. However, in conformity with previous observations (Jakob et al., 1989; Deighton et al., 1990; B6hm et al., 1994) in the isoprenaline-augmented human isolated myocardium, acetylcholine decreased contractility in both atrial and ventricular preparations after prior exposure to noradrenaline. The negative inotropic effect of muscarinic cholinergic agents (antagonized by atropine) is well known, but their positive inotropic action, though reported in some animal species (rat atria, Imai and Ohta, 1982 ; guineapig papillary muscles, Korth and Kiihlkamp, 1987; guinea-pig atria, Eglen et al., 1988; chick ventricles, Tsuji et al., 1987) , has not been reported in humans (see Jakob et al., 1989; Deighton et al., 1990; B6hm et al., 1994) . The reasons for this discrepancy are not entirely clear. However, in contrast to our investigations performed in non-diseased hearts and with acetylcholine in ventricular trabeculae, previous au-thors (Jakob et al., 1989; Deighton et al., 1990; B6hm et al., 1994) studied the effects of carbachol on papillary muscles obtained from hearts removed from patients undergoing heart transplantation surgery.
The precise receptor mechanisms involved in the positive inotropic effects of muscarinic cholinergic agents are not well understood. In the rat atria (Imai and Ohta, 1982) , guinea-pig papillary muscle (Korth and Kiihlkamp, 1987) and chick ventricles , the positive inotropic effect was antagonized by atropine and, in the last two tissues, it was also shown that the effect, being unaffected by prior reserpinization (Korth and Kiihlkamp, 1987) or propranolol , was independent of endogenous catecholamines. In accordance with these observations, we also found that atropine not only blocked the negative inotropic effect in the atria, but also the positive inotropic responses in both atria and ventricles; these responses remained unaltered after exposure to propranolol. Thus, the results show that both the negative and positive inotropic effects of acetylcholine in the human isolated myocardium are mediated by muscarinic receptors.
Subtypes of muscarinic receptors involved in acetylcholine responses
Although, at present, highly selective antagonists at muscarinic receptors are not available, a combination of relatively selective antagonists can be employed to characterize the muscarinic receptor subtypes. In the present investigation, we used three such antagonists having different selectivity profiles, namely pirenzepine (M l>M 3>M2), AF-DX 116 (M 2>M I>M 3) and HHSiD (M 3 >__ M 1 >> M 2) (Doods et al., 1994) . However, it should be pointed out that the affinity values of these relatively selective antagonists obtained in the present experiments in the human myocardium are further prejudiced by the complex nature of acetylcholine responses.
Involvement of the muscarinic M 2 receptor subtype
The present study showed that AF-DX 116 most effectively antagonized the atrial negative inotropic (Fig. 3) and ventricular positive inotropic (Fig. 4) effects of acetylcholine; the concentration-response curves were clearly shifted to the right. The calculated apparent pK B values of AF-DX 116 in the atria (6.7 +_ 0.4) and ventricles (6.7 _+ 0.6) against the negative and positive inotropic responses, respectively, to acetylcholine reasonably match with its pK i values (7.14 _+ 0.06 and 7.18 _+ 0.06, respectively) in the two tissues for the displacement of [3H]N-methyl scopolamine in guinea-pig membranes . Thus, it appears that the muscarinic M 2 receptor subtype mediates both the negative (in atria) and positive (in ventricles) inotropic responses. This conclusion is in agreement with the demonstration of the muscarinic M 2 receptor mRNA and protein in the human heart (Maeda et al., 1988; Caulfield, 1993) . Moreover, it is now well established that muscarinic M 2 receptors are coupled to three signal transduction pathways (Schimerlik, 1989 ): (i) inhibition of adenylyl cyclase to reduce cAMP (Fleming et al., 1987) , (ii) opening of potassium channels (Ray and MaCleod, 1993) , and (iii) hydrolysis of phosphatidylinositol. The first two may contribute to the negative inotropic response associated with muscarinic receptor stimulation (Hanf et al., 1993) , while the third may induce positive inotropic responses (Mizushima et al., 1987; Kohl et al., 1990) . Although the exact molecular processes are unclear, it is believed that the two opposite functional responses are mediated via muscarinic M 2 receptors coupled to different G-proteins and occurring in different affinity states: a high affinity state associated with inhibition of adenylyl cyclase and a low affinity state associated with the phosphatidylinositol breakdown (Brown and Brown, 1984) .
A recent study comparing muscarinic K ÷ channels in the human atrium and ventricle (Koumi and Wasserstrom, 1994) showed that the acetylcholine-induced K ÷ current in whole cell preparations from the two tissues exhibited essentially similar characteristics, except with regard to the channel density. Acetylcholine-induced K ÷ current in atria was approximately 2-3 times higher than that in ventricles. Another study on the comparison of coupling of muscarinic receptors in guinea-pig atrial and ventricular myocardium showed that atrial and ventricular receptors were similar, but receptor coupling to cyclase inhibition or phosphatidylinositol hydrolysis was distinguishable (Woodcock et al., 1987) . Thus, it is possible that all three pathways operate to mediate the observed tissue responses, but their importance may vary in different tissues and/or conditions. Based on the effect of acetylcholine on the baseline contractility (without prior stimulation with, for example, noradrenaline), it would appear that the coupling of the rnuscarinic M 2 receptors to adenylyl cyclase (negatively) and K ÷ channels may be more important in the atrial tissue, whereas in the ventricular tissue the muscarinic M 2 receptors probably couple preferentially to phosphatidylinositol hydrolysis. However, it is possible that the coupling can alter in different conditions. Indeed, it is interesting to recall that in the human ventricular myocardium a concentration-dependent negative inotropic effect was seen after pre-stimulation with sympathomimetic agents (Jakob et al., 1989; Landzberg et al., 1994; present results) .
Involvement of the muscarinic M 1 receptor subtype
Experiments with AF-DX 116 and HHSiD in atrial tissue showed that the positive inotropic effect of acetylcholine, observed with high concentrations and only when the atrial contractility had been depressed, was not attenuated and seemed to be potentiated by these compounds, apparently due to the elimination of the negative inotropic effect. On the other hand, pirenzepine seemed to attenuate this response, thereby accentuating the preceding negative inotropic effect (Fig.  3) . It therefore appears that the acetylcholine-induced increase in depressed contractility is mediated by the muscarinic M 1 receptor subtype rather than the M 2 or M 3 subtype. Although HHSiD has been reported to be a more potent antagonist against M 1 than M 2 receptors (see Doods et al., 1994) , this apparently does not seem to hold true for the human heart, where this compound blocked M 2 receptor mediated responses (negative inotropism in atria and positive inotropism in ventricles) more effectively.
The conclusion that the muscarinic M 1 receptor subtype mediates acetylcholine-induced increases in atrial contractility is further substantiated by the resuits obtained with McN-A-343, which in the radioligand binding assays has similar affinities for the muscarinic M 1 and M 2 receptor subtypes, but in functional assays, probably due to differences in intrinsic efficacy and/or tissue receptor reserve, shows selectivity for the muscarinic M 1 receptor subtype (Eglen et al., 1987) . Indeed, McN-A-343 failed to decrease atrial or increase ventricular contractility (Fig. 5) , thus ruling out the activation of muscarinic M 2 receptor subtype in the human heart. This compound, however, mimicked acetylcholine (higher concentrations) in increasing atrial contractility, once this had been depressed by prior administration of low concentrations of acetylcholine (Fig. 6) . The reversal of the negative inotropic effect of acetylcholine by McN-A-343 cannot be due to a blockade of muscarinic M 2 receptors, since the effect of McN-A-343 was antagonized by pirenzepine. The apparent pK B value of pirenzepine against McN-A-343 (8.57 + 0.33) was similar to the binding affinity of the drug at the human cloned muscarinic M t receptor (PKi: 8.20 + 0.13; Dorje et al., 1991) , thus confirming the involvement of muscarinic M 1 receptor subtype. Additional evidence for functional atrial muscarinic M 1 receptors comes from studies of Pitschner and Wellstein (1988) , who observed that low doses (< 3 mg) of pirenzepine decrease heart rate in human subjects. Similarly, the bradycardia caused by low doses of atropine in humans may also be related to blockade of muscarinic M 1 receptors ; present results), rather than central vagal stimulation (Weiner, 1990) . Kellar et al. (1985) examined the binding of [3H]acetylcholine and suggested that most of the muscarinic M E sites had a high affinity for acetylcholine, whereas the majority of muscarinic M l sites had a low affinity for acetylcholine. This is in agreement with our observations that the positive inotropic response in the atrial trabeculae was obtained with high concentrations of acetylcholine (10 -4 or 10 -3 M). It is possible that the muscarinic M 1 receptors mediating increases in atrial contractility are coupled to phosphatidylinositol hydrolysis (Gallo et al., 1993; Wess, 1993) .
In conclusion, the present investigation in the human isolated myocardium showed that: (i) in addition to the generally accepted negative inotropic effect, acetylcholine also causes positive inotropic effects at similar concentrations in human ventricular trabeculae and these negative and positive inotropic responses are mediated by the muscarinic M 2 receptor subtype, possibly having preferential coupling to adenylyl cyclase (negatively) and K ÷ channels in atria, and to phosphoinositol breakdown in ventricles, (ii) in trabeculae prestimulated with noradrenaline, acetylcholine elicited negative inotropic responses in both atrial and ventricular trabeculae, suggesting that the preferential coupling in the ventricles can be altered, and (iii) when atrial contractility has already been depressed, high concentrations of acetylcholine as well as McN-A-343 can increase the atrial contractility back towards baseline values via the muscarinic M 1 receptor subtype. The physiological relevance of the atrial muscarinic M 1 receptor is not yet clear.
